Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?

Theodor Asgeirsson; Sen Zhang; Anthony J. Senagore

doi:10.1016/j.soc.2010.06.003

Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?

Theodor Asgeirsson
, Sen Zhang
, Anthony J. Senagore

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

Original language	English (US)
Pages (from-to)	861-873
Number of pages	13
Journal	Surgical Oncology Clinics of North America
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/j.soc.2010.06.003
State	Published - Oct 2010
Externally published	Yes

Keywords

Colon cancer
Follow-up
Rectal cancer
Surveillance

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/j.soc.2010.06.003

Cite this

@article{55adf64b66974532ba6b4d0499aa8c34,

title = "Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?",

abstract = "In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75\% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.",

keywords = "Colon cancer, Follow-up, Rectal cancer, Surveillance",

author = "Theodor Asgeirsson and Sen Zhang and Senagore, \{Anthony J.\}",

year = "2010",

month = oct,

doi = "10.1016/j.soc.2010.06.003",

language = "English (US)",

volume = "19",

pages = "861--873",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Optimal follow-up to curative colon and rectal cancer surgery

T2 - How and for how long?

AU - Asgeirsson, Theodor

AU - Zhang, Sen

AU - Senagore, Anthony J.

PY - 2010/10

Y1 - 2010/10

N2 - In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

AB - In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

KW - Colon cancer

KW - Follow-up

KW - Rectal cancer

KW - Surveillance

UR - https://www.scopus.com/pages/publications/77957130015

UR - https://www.scopus.com/pages/publications/77957130015#tab=citedBy

U2 - 10.1016/j.soc.2010.06.003

DO - 10.1016/j.soc.2010.06.003

M3 - Review article

C2 - 20883959

AN - SCOPUS:77957130015

SN - 1055-3207

VL - 19

SP - 861

EP - 873

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 4

ER -

Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this